Zivo Bioscience, Inc. (ZIVO) stock
ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Zivo Bioscience total assets
Total assets on the balance sheet at the end of each period.
Zivo Bioscience's total assets was $559.45K at Sep 30, 2025. For fiscal 2024 it was $1.64M, up 195.7% from the year before. Over ten years it grew 32.1% a year on average. The highest annual figure on record is $8.99M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.64M | +195.7% |
| FY2023 | Dec 31, 2023 | $555.72K | -73.8% |
| FY2022 | Dec 31, 2022 | $2.12M | -76.4% |
| FY2021 | Dec 31, 2021 | $8.99M | +3983.1% |
| FY2020 | Dec 31, 2020 | $220.18K | -40.4% |
| FY2019 | Dec 31, 2019 | $369.39K | -10.2% |
| FY2018 | Dec 31, 2018 | $411.51K | +23.8% |
| FY2017 | Dec 31, 2017 | $332.28K | -54.9% |
| FY2016 | Dec 31, 2016 | $737.29K | +914.4% |
| FY2015 | Dec 31, 2015 | $72.68K | -28.6% |
| FY2014 | Dec 31, 2014 | $101.86K | -95.3% |
| FY2013 | Dec 31, 2013 | $2.17M | +829.2% |
| FY2012 | Dec 31, 2012 | $234.00K | -49.5% |
| FY2011 | Dec 31, 2011 | $463.49K | +36.4% |
| FY2010 | Dec 31, 2010 | $339.92K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $559.45K | +12.9% |
| Q2 FY2025 | Jun 30, 2025 | $703.33K | +22.2% |
| Q1 FY2025 | Mar 31, 2025 | $1.33M | +63.1% |
| Q4 FY2024 | Dec 31, 2024 | $1.64M | +195.7% |
| Q3 FY2024 | Sep 30, 2024 | $495.59K | -76.4% |
| Q2 FY2024 | Jun 30, 2024 | $575.59K | -19.0% |
| Q1 FY2024 | Mar 31, 2024 | $816.40K | -27.6% |
| Q4 FY2023 | Dec 31, 2023 | $555.72K | -73.8% |
| Q3 FY2023 | Sep 30, 2023 | $2.10M | -47.1% |
| Q2 FY2023 | Jun 30, 2023 | $710.33K | -87.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.13M | -85.3% |
| Q4 FY2022 | Dec 31, 2022 | $2.12M | -76.4% |
| Q3 FY2022 | Sep 30, 2022 | $3.97M | -63.8% |
| Q2 FY2022 | Jun 30, 2022 | $5.86M | -47.2% |
| Q1 FY2022 | Mar 31, 2022 | $7.69M | +1084.8% |
| Q4 FY2021 | Dec 31, 2021 | $8.99M | +3983.1% |
| Q3 FY2021 | Sep 30, 2021 | $10.97M | +8311.2% |
| Q2 FY2021 | Jun 30, 2021 | $11.10M | +4885.8% |
| Q1 FY2021 | Mar 31, 2021 | $648.88K | +262.7% |
| Q4 FY2020 | Dec 31, 2020 | $220.18K | -40.4% |
| Q3 FY2020 | Sep 30, 2020 | $130.44K | +86.6% |
| Q2 FY2020 | Jun 30, 2020 | $222.70K | +98.4% |
| Q1 FY2020 | Mar 31, 2020 | $178.92K | +72.4% |
| Q4 FY2019 | Dec 31, 2019 | $369.39K | -10.2% |
| Q3 FY2019 | Sep 30, 2019 | $69.90K | -74.9% |
| Q2 FY2019 | Jun 30, 2019 | $112.23K | -84.8% |
| Q1 FY2019 | Mar 31, 2019 | $103.76K | -96.3% |
| Q4 FY2018 | Dec 31, 2018 | $411.51K | +23.8% |
| Q3 FY2018 | Sep 30, 2018 | $278.53K | -80.5% |
| Q2 FY2018 | Jun 30, 2018 | $739.67K | +259.9% |
| Q1 FY2018 | Mar 31, 2018 | $2.79M | +125.0% |
| Q4 FY2017 | Dec 31, 2017 | $332.28K | -54.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.43M | +90.6% |
| Q2 FY2017 | Jun 30, 2017 | $205.54K | +126.3% |
| Q1 FY2017 | Mar 31, 2017 | $1.24M | +254.3% |
| Q4 FY2016 | Dec 31, 2016 | $737.29K | +914.4% |
| Q3 FY2016 | Sep 30, 2016 | $749.91K | – |
| Q2 FY2016 | Jun 30, 2016 | $90.85K | – |
| Q1 FY2016 | Mar 31, 2016 | $349.60K | – |
| Q4 FY2015 | Dec 31, 2015 | $72.68K | – |
See a number that looks wrong?